Allison Institute announces appointment of four new members
The James P. Allison Institute™ at The University of Texas MD Anderson Cancer Center today announced the appointment of four new members, Eric Gardner, Pharm.D., Ph.D., Betty Kim, M.D., Ph.D., Rodrigo Romero, Ph.D., and Hojong Yoon, Ph.D. These exceptional scientists will advance the institute’s ongoing work to attain a deeper understanding of the many aspects of the tumor-immune response in order to bring the benefits...
MD Anderson and SOPHiA GENETICS announce strategic collaboration to accelerate AI-driven precision oncology
The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites SOPHiA GENETICS...
Leading cancer research centers reinforce importance of safe and effective HPV vaccination to prevent cancer
62 NCI-designated cancer centers, leading national organizations and the University of Puerto Rico Comprehensive Cancer Center jointly endorse...
MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies for cell and gene therapies
Agreement focuses on rimiducid, an agent used to activate certain safety switch technologies in cell therapies
Phoenix receives a supply of rimiducid and support to seek regulatory approval of a new proprietary injectable formulation, retaining exclusive rights for use in its novel in vivo gene therapy programs
MD Anderson receives rights to the new formulation of rimiducid for use with its inducible switches exclusively in ex vivo cell...
MD Anderson and TOPPAN Holdings announce strategic alliance to co-develop organoid technology for evaluating cancer treatments
3D cell culture technology may allow researchers to rapidly test a variety of treatments directly on patient biopsies
Teams will evaluate technology...
UT MD Anderson and Texas Children’s Hospital announce $150 million gift from Kinder Foundation to launch Kinder Children’s Cancer Center
The University of Texas MD Anderson Cancer Center and Texas Children’s Hospital today announced a $150 million gift from Kinder Foundation...
MD Anderson and UT Austin launch joint initiative to advance breakthroughs in cancer research
The University of Texas MD Anderson Cancer Center and The University of Texas at Austin have launched a joint initiative, the Collaborative...
UT MD Anderson and Texas Children’s Hospital Announce Joint Venture to End Childhood Cancer
The University of Texas MD Anderson Cancer Center and Texas Children’s Hospital have announced a transformational collaboration dedicated...
MD Anderson and Myriad Genetics form strategic alliance to evaluate clinical utility of Myriad’s molecular residual disease assay
The University of Texas MD Anderson Cancer Center and Myriad Genetics, Inc. today announced a five-year strategic alliance to accelerate the...
MD Anderson’s Lauren Averett Byers receives TAMEST O’Donnell Award for seminal contributions to lung cancer research
Lauren Averett Byers, M.D., professor of Thoracic/Head & Neck Medical Oncology at The University of Texas MD Anderson Cancer Center...